Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ATHX

Athersys (ATHX)

Athersys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATHX
DateTimeSourceHeadlineSymbolCompany
08/01/202423:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
23/12/202309:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
22/12/202303:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
17/11/202300:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
18/10/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
17/10/202307:52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
13/10/202300:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
12/10/202300:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/10/202323:30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
07/10/202308:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
07/10/202308:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
04/10/202307:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
04/10/202307:30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
03/10/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
03/10/202308:04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
26/09/202306:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
22/09/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
20/09/202302:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
19/09/202311:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
19/09/202311:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
15/09/202301:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
15/09/202300:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
14/09/202307:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
11/09/202322:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
07/09/202304:45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
22/08/202304:36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
19/08/202300:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
18/08/202311:30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
18/08/202306:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
17/08/202307:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
 Showing the most relevant articles for your search:NASDAQ:ATHX